<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He Z</submitter><funding>Natural Science Foundation of China</funding><funding>Guangdong Basic and Applied Basic Research Foundation</funding><funding>Xinglin young scholar construction of high levels university projects of Guangzhou University of Chinese Medicine</funding><funding>Natural Science Foundation of Guangdong Province</funding><funding>Open Research Fund of Key Laboratory of Smart Drug Delivery</funding><pagination>15</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9841648</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Malaria remains a serious threat to global public health. With poor efficacies of vaccines and the emergence of drug resistance, novel strategies to control malaria are urgently needed.&lt;h4>Results&lt;/h4>We developed erythrocyte membrane-camouflaged nanoparticles loaded with artemether based on the growth characteristics of Plasmodium. The nanoparticles could capture the merozoites to inhibit them from repeatedly infecting normal erythrocytes, owing to the interactions between merozoites and heparin-like molecules on the erythrocyte membrane. Modification with a phosphatidylserine-targeting peptide (CLIPPKF) improved the drug accumulation in infected red blood cells (iRBCs) from the externalized phosphatidylserine induced by Plasmodium infection. In Plasmodium berghei ANKA </pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection.</pubmed_title><pmcid>PMC9841648</pmcid><funding_grant_id>SDD2018-04</funding_grant_id><funding_grant_id>2022A1515011312</funding_grant_id><funding_grant_id>A1-2601-21-414-001Z22</funding_grant_id><funding_grant_id>82204628</funding_grant_id><funding_grant_id>SDD2022-01</funding_grant_id><funding_grant_id>81873218</funding_grant_id><funding_grant_id>2020A1515110336</funding_grant_id><pubmed_authors>Pan Z</pubmed_authors><pubmed_authors>Liao X</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Ru L</pubmed_authors><pubmed_authors>Huang Q</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>He Z</pubmed_authors><pubmed_authors>Yu C</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Liang J</pubmed_authors><pubmed_authors>Yu W</pubmed_authors><pubmed_authors>Zeng F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection.</name><description>&lt;h4>Background&lt;/h4>Malaria remains a serious threat to global public health. With poor efficacies of vaccines and the emergence of drug resistance, novel strategies to control malaria are urgently needed.&lt;h4>Results&lt;/h4>We developed erythrocyte membrane-camouflaged nanoparticles loaded with artemether based on the growth characteristics of Plasmodium. The nanoparticles could capture the merozoites to inhibit them from repeatedly infecting normal erythrocytes, owing to the interactions between merozoites and heparin-like molecules on the erythrocyte membrane. Modification with a phosphatidylserine-targeting peptide (CLIPPKF) improved the drug accumulation in infected red blood cells (iRBCs) from the externalized phosphatidylserine induced by Plasmodium infection. In Plasmodium berghei ANKA </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-05T12:56:35.13Z</modification><creation>2025-04-05T12:56:35.13Z</creation></dates><accession>S-EPMC9841648</accession><cross_references><pubmed>36647056</pubmed><doi>10.1186/s12951-022-01709-x</doi></cross_references></HashMap>